Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
national blog main
national top stories
6
×
san diego blog main
6
×
san diego top stories
san francisco blog main
startups
6
×
boston blog main
boston top stories
cancer
deals
new york blog main
new york top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
national
novartis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
aducanumab
alzheimer's disease
asklepios biopharmaceutical
biogen
bristol-myers squibb
cancer immunotherapy
cell therapy
What
new
6
×
bio
drug
roundup
biotech
drugs
medicines
today
activity
advance
aiming
ambys
approval
approvals
athena
bails
big
biogen
biogen’s
biologic
biology
biopharmaceutical
brand
bridgebio
cancer
capital
car
ceo
chief
clamped
companies
control
convo
countouriotis
covid
cytokine
deadly
deal
debuted
delays
Language
unset
Current search:
new
×
biotech
×
startups
×
" national top stories "
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
